Skip to main content

ERC

News
  • Participate
    • Patients
    • Doctors
    • Investors
  • Products
    • Gliovac/ERC1671
  • Media
    • News
    • Publications
  • About
    • Executive Management
    • Executive board
    • Scientific board
    • Milestone achievements
  • Contact
NewsPublications
15May2016

Approval for open phase II study

ULB Belgium’s ethical commitee has approved the protocol for an open phase II study of standard treatments in combination with Gliovac/ERC1671 vs standard treatments ...
29Mar2016

Interest to use our technology for other cancers

Based on the visibility of preliminary results for GBM, independent groups expressed their strong interest to use the technology for other cancers.

Pages

  • « first
  • 1
  • 2
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Cookie and Privacy Policy for more details.
Close
Copyright © 2001-2022 ERC.SA. All rights reserved.
Made byKonnu
Cookie and Privacy PolicyTerms & Conditions
Top